“勇敢战斗”的叙事陷阱与医疗资源的性别定价The "Valiant Fight" Scam and the Gendered Pricing of Healthcare
新闻里那个词用得极其典型："valiantly fought and beaten"（英勇地战斗并击败）。这种叙事将医疗过程英雄化，把一个生物学上的随机事件或医疗干预的结果，包装成个体意志的胜利。这正是第三章所说的“武器化叙事”——通过赋予某种情感色彩，将原本冰冷的医疗资源分配问题，转化为一个关于勇气和尊严的个人故事。
注意文中提到的 CAR-T 疗法。这种顶尖的免疫疗法是极少数经济上位者才能触及的资源。当一个 78 岁的男性演员能够通过这种昂贵的、前沿的医疗手段“击败”淋巴瘤时，这种“胜利”本质上是资本与医疗资源在男性中心叙事下的精准投放。而与此同时，无数女性在面对同样或更基础的妇科疾病时，却在结构性暴力中被忽视。正如我在书中提到的，美国 NIH 对艾滋病的投入是每年 30 亿美元，而对子宫肌瘤等女性特有疾病的预算低到可怜。这种资源分配的极不对称，就是典型的 structural violence。
最后，Laura Dern 的评价——"a true and noble gentleman"（一个真正且高贵的绅士），再次完成了这次共谋。在男性中心叙事的元暴力下，一个拥有资源、地位且被定义为“绅士”的男性，其生命轨迹被赋予了天然的崇高感。而这种崇高感，恰恰是通过抹除他作为资源垄断者的身份，将其简化为“一个普通的家伙 (regular bloke)”来完成的。这种美化，让人们忘记了在医疗资源这个终极博弈场中，谁拥有真正的定价权。
The phrasing in this report is textbook: "valiantly fought and beaten." By heroicizing the medical process, it transforms a biological event or a result of clinical intervention into a victory of individual will. This is the "weaponization of expression" I discussed in Chapter 3—using emotional framing to pivot from the cold reality of resource distribution to a curated story of courage and dignity.
Consider the mentioned CAR-T therapy. This cutting-edge immunotherapy is a resource accessible only to a tiny fraction of the economic elite. When a 78-year-old male actor "beats" lymphoma via such expensive, avant-garde medicine, this "victory" is actually the precision deployment of capital and medical resources within a masculine-centric narrative. Meanwhile, countless women are structurally ignored when facing similar or even more basic gynecological crises. As I've noted, the NIH pours billions into HIV research while the budget for conditions like uterine fibroids is negligible. This asymmetry is the definition of structural violence.
Finally, Laura Dern’s description of him as a "true and noble gentleman" completes the complicity. Under the meta-violence of the masculine-centric narrative, a man with status and resources is granted an innate sense of nobility. This nobility is achieved by erasing his identity as a resource monopolist and reducing him to a "regular bloke." Such beautification ensures we forget who actually holds the pricing power in the ultimate existential war: the battle for survival through medical access.